Abstract
Abstract Background: Patients affected by uterine fibroids were evaluated to define inclusion and exclusion criteria for treatment with Magnetic Resonance-guided Focus Ultrasound Surgery (MRgFUS), the non-invasive
Highlights
Fibroids are benign tumours growing in the uterus
Sedation instead of general anaesthesia, considerably reduced recovery times and a definitely better quality of life for the patient are all advantages offered by Magnetic Resonance-guided Focus Ultrasound Surgery (MRgFUS)
Patients were initially examined by a gynaecologist for clinical evaluation of symptoms and their possibility to participate in the MRgFUS trial
Summary
Fibroids are benign tumours growing in the uterus They are symptomatic in up to 25% of women in childbearing age [1]. Hysterectomy is the most common treatment for uterine fibroids [3], but it implies long hospitalization, post-operative complications and loss of the organ [4]. All these implications have led during the years to an increasing demand for noninvasive resolving techniques. Patients affected by uterine fibroids were evaluated to define inclusion and exclusion criteria for treatment with Magnetic Resonance-guided Focus Ultrasound Surgery (MRgFUS), the non-invasive technique considered as an efficient alternative to hysterectomy and myomectomy
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
